Osteoarthritis in Latin America: Study of Demographic and Clinical Characteristics in 3040 Patients.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsReginato, Anthony M
Torres, Adrian R
Esquivel, Jorge A
Felipe, Oscar Jair
Blas, Jorge Roman
Molina, José F
Gil, María L
Garcia, Abraham K
Gutierrez, Carmen E
Muñoz Louis, Roberto
MetadataShow full item record
CitationOsteoarthritis in Latin America: Study of Demographic and Clinical Characteristics in 3040 Patients. 2015, 21 (8):391-7 J Clin Rheumatol
PublisherWolters Kluwer Health, Inc.
JournalJournal of clinical rheumatology (J Clin Rheumatol.)
AbstractBACKGROUND: Latin America is a heterogeneous region made up of different populations, cultures, latitudes, altitudes, and immigrants from different areas and ethnic groups. OBJECTIVE: The purpose of this study is to describe the clinical and demographic profile of patients with osteoarthritis (OA) evaluated by a selected group of rheumatologists in 13 Latin American countries. METHODS: A descriptive, observational, cross-sectional study was conducted in 13 Latin American countries of patients with symptomatic OA. Data were collected over a 3-month period using an ad hoc questionnaire to evaluate the clinical and demographic features of OA seen by rheumatologists. RESULTS: Among the 3040 patients, their average age was 62.5 years, and female-to-male ratio was 4.8:1. Patients with body mass index of greater than 30 kg/m or obesity was found in 38.2%. Approximately 88% had primary OA. Joints with OA were as follows: knee 31.2%, hand 9.5%, hand and knee 22.9%, proximal and distal interphalangeal joints (erosive OA) 6.5%, axial 6.6%, and hip 1.3%. Approximately 88.5% had radiographic severity of grade 2 or 3 on Kellgren-Lawrence scale (0-4). Nonsteroidal anti-inflammatory drugs were the predominant OA treatment included in combinations with glucosamine sulfate/chondroitin and viscosupplementation. Associated comorbidities included hypertension (39%), obesity (36.3%), diabetes mellitus (12%), and without comorbidity (12.7%). CONCLUSIONS: This is 1 of the largest population studies that evaluated the characteristics of OA in 3040 patients evaluated by rheumatologists in 13 Latin American countries. This study provides important data for each Latin American country to develop new health care planning in management of OA.
DescriptionEl texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.
- Characterization of individuals with osteoarthritis in the United States and their use of prescription and over-the-counter supplements.
- Authors: Lane NE, Ivanova J, Emir B, Mobasheri A, Jensen MG
- Issue date: 2021 Mar
- Commentary on recent therapeutic guidelines for osteoarthritis.
- Authors: Cutolo M, Berenbaum F, Hochberg M, Punzi L, Reginster JY
- Issue date: 2015 Jun
- Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study.
- Authors: Cimmino MA, Sarzi-Puttini P, Scarpa R, Caporali R, Parazzini F, Zaninelli A, Marcolongo R
- Issue date: 2005 Aug
- Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
- Authors: Detora LM, Krupa D, Bolognese J, Sperling RS, Ehrich EW
- Issue date: 2001 Nov
- How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative.
- Authors: Kingsbury SR, Hensor EM, Walsh CA, Hochberg MC, Conaghan PG
- Issue date: 2013